#What Happened with Bank of Montreal's Corporate Loans?
Bank of Montreal has recently taken significant steps to manage its corporate loan risk by offloading $5 billion in corporate loan risk through two distinct transactions. This strategic move aligns BMO with a competitive landscape of Canadian lenders who are eager to address the growing investor appetite for synthetic risk transfers.
The transactions occurred in the last two months and were split equally between BMO’s Muskoka program and the Algonquin program, with each program responsible for $2.5 billion in corporate loans. The Muskoka program focuses on large corporate borrowers, whereas Algonquin serves mid-market companies.
#How Are These Transactions Structured?
Understanding synthetic risk transfers is essential to grasp the significance of these deals. In a synthetic risk transfer, the bank retains its loans on the balance sheet while compensating external investors for shouldering the first portion of potential losses. This arrangement allows the bank to gain regulatory capital relief without the need to sell any loans, and it offers investors compensation for assuming the higher risk associated with the initial tranche of losses.
In BMO’s case, the first-loss portion for the Muskoka program accounted for over 7% of its $2.5 billion portfolio, while the Algonquin program’s first-loss tranche was slightly lower at over 6%. The pricing for Muskoka came in below 700 basis points, and Algonquin's pricing fell into the mid-700 basis-point range.
A sharper way to see the markets in just 5 minutes.
Same news, different lens. We cut through the noise and hand you the overlooked ideas and the deeper read the crowd misses. Join 38,000+ investors seeing the markets differently.
#Why Is Canada Seeing an Increase in Synthetic Risk Transfers?
BMO's actions are indicative of a wider trend among Canadian banks. In fact, major players like Toronto-Dominion Bank, Royal Bank of Canada, and National Bank of Canada have also conducted similar synthetic risk transfer transactions in 2026. This collective movement highlights a moment when Canadian banks are actively engaging in synthetic risk transfers, anticipating a sixth consecutive year of record issuance within the global synthetic risk transfer market, heavily influenced by European and Canadian institutions.
#What Does This Mean for Investors?
The favorable pricing achieved by BMO reveals critical insights about market dynamics. When a bank can secure a large corporate synthetic risk transfer under 700 basis points, it indicates a strong demand from investors for these kinds of products. The slightly higher pricing for Algonquin's mid-market focus, sitting in the mid-700s range, demonstrates the breadth of competition and the differing risk appetites among investors.
With banks like TD, RBC, National Bank, and BMO increasingly leveraging these transactions, synthetic risk transfers are becoming essential tools for capital management for Canada's largest lenders. Investors looking for opportunities in this evolving landscape should monitor these developments closely.